RPRX icon

Royalty Pharma

312 hedge funds and large institutions have $8.16B invested in Royalty Pharma in 2023 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 138 increasing their positions, 113 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

12% less capital invested

Capital invested by funds: $9.31B → $8.16B (-$1.15B)

24% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 46

25% less funds holding in top 10

Funds holding in top 10: 86 (-2)

Holders
312
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$40.5M
Puts
$11.8M
Net Calls
Net Calls Change

Top Buyers

1 +$32.3M
2 +$29.2M
3 +$28.5M
4
SCM
Suvretta Capital Management
New York
+$28.5M
5
GC
GMT Capital
Georgia
+$25.2M
Name Holding Trade Value Shares
Change
Change in
Stake
176
$991K
177
$989K
178
$971K
179
$946K
180
$941K
181
$909K
182
$895K
183
$886K
184
$881K
185
$865K
186
$806K
187
$804K
188
$797K
189
$792K
190
$787K
191
$782K
192
$782K
193
$769K
194
$766K
195
$729K
196
$700K
197
$679K
198
$664K
199
$640K
200
$635K